{"groups":[{"description":"Alemtuzumab given together with busulfan and cyclophosphamide followed by a donor stem cell transplant.\n\nalemtuzumab\n\nbusulfan\n\ncyclophosphamide\n\nmethotrexate\n\ntacrolimus\n\nallogeneic hematopoietic stem cell transplantation\n\nperipheral blood stem cell transplantation","id":"FG000","title":"Alemtuzumab"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}